Stock Split History
How to Retire on Monthly Dividends »    AKTX Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akari Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for acute and chronic inflammation, specifically through the inhibition of the complement (C5) and leukotriene pathways. Co.'s primary product candidate, nomacopan, inhibits both terminal C5 activation and leukotriene B4 (LTB4). Co.'s clinical targets for nomacopan are orphan inflammatory diseases where the inhibition of both C5 and LTB4 are implicated, including bullous pemphigoid, pediatric hematopoietic stem cell transplant-associated thrombotic microangiopathy, and as well as inflammatory conditions in the eye and lung including dry eye, dry AMD and COVID-19 pneumonia. According to our Akari Therapeutics PLC stock split history records, Akari Therapeutics PLC has had 1 split.
Akari Therapeutics PLC stock split history picture
Akari Therapeutics PLC (AKTX) has 1 split in our Akari Therapeutics PLC stock split history database. The split for AKTX took place on August 17, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of AKTX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.

When a company such as Akari Therapeutics PLC conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the Akari Therapeutics PLC stock split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Akari Therapeutics PLC shares, starting with a $10,000 purchase of AKTX, presented on a split-history-adjusted basis factoring in the complete Akari Therapeutics PLC stock split history. Akari Therapeutics PLC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/18/2014
End date: 03/28/2024
Start price/share: $119.80
End price/share: $1.86
Dividends collected/share: $0.00
Total return: -98.44%
Average Annual Total Return: -34.89%
Starting investment: $10,000.00
Ending investment: $155.64
Years: 9.70
Date Ratio
08/17/20231 for 20
NRx Pharmaceuticals, Inc. (NRXP)
Tritium DCFC Limited (DCFC)
Pluri Inc. (PLUR)
Rent the Runway, Inc. (RENT)
Castor Maritime Inc. (CTRM)
ETAO International Co., Ltd. (ETAO)
Aterian, Inc. (ATER)
Chipotle Mexican Grill, Inc. (CMG)
Moleculin Biotech, Inc. (MBRX)
Longeveron Inc. (LGVN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Akari Therapeutics PLC

Akari Therapeutics PLC Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.